Complete Filing Data
Burford Capital Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $3.13 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Burford Capital Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $62.6M | $146.5M | $610.5M | $30.5M | -$28.8M | $143.3M | $300.5M | $317.6M |
| Revenue * | $413.4M | $546.1M | $1.09B | $319.2M | $152.2M | $359.1M | $379.2M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$10.3M | $2.8M | -$39.7M | $44.1M | -$2.2M | -$11.5M | -$17.3M | |
| Operating Income Loss | $232.1M | $390.6M | $815.7M | $195.0M | $68.6M | $208.8M | $396.4M | |
| Operating Expenses | $181.2M | $155.5M | $271.2M | $124.3M | $148.7M | $119.1M | $138.1M | |
| Nonoperating Income Expense | -$148.1M | -$137.0M | -$77.4M | -$85.9M | -$65.8M | -$28.3M | -$36.8M | |
| Net Income Loss Attributable To Noncontrolling Interest | $9.6M | $83.1M | $107.7M | $67.0M | $21.8M | $13.7M | $27.2M | |
| Income Tax Expense Benefit | $11.8M | $24.0M | $20.1M | $11.6M | $9.7M | $23.5M | $31.9M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $84.0M | $253.6M | $738.3M | $109.0M | $2.8M | $180.5M | $359.6M | |
| General And Administrative Expense | $38.4M | $31.0M | $33.7M | $29.7M | $30.5M | $21.5M | $22.4M | |
| Comprehensive Income Net Of Tax | $52.3M | $149.3M | $570.8M | $74.6M | -$31.0M | $131.7M | $283.3M | |
| Compensation Expense Excluding Cost Of Good And Service Sold | $22.3M | $29.2M | $32.7M | $24.3M | $22.1M | $22.8M | $24.5M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $61.9M | $232.4M | $678.5M | $141.5M | -$9.2M | $145.4M | $310.4M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $9.6M | $83.1M | $107.7M | $67.0M | $21.8M | $13.7M | $27.2M | |
| Deferred Income Tax Expense Benefit | $13.3M | -$16.9M | $5.9M | $9.4M | $11.6M | $21.1M | $27.9M | |
| Income Taxes Paid | $23.2M | $19.5M | $14.1M | $1.8M | $1.3M | $11.0M | $694.0K | |
| Deferred Income Tax Liabilities Net | $47.1M | $35.9M | $50.9M | $51.3M | $38.8M | $27.9M | ||
| Deferred Income Tax Assets Net | $2.7M | $3.3M | $927.0K | $6.4M | $78.0K | $256.0K | ||
| Interest Expense Nonoperating | $151.0M | $135.6M | $99.1M | $78.3M | ||||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $8.5M | $4.1M | $5.6M | -$10.7M | -$1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | -$19.2M | $88.3M | $30.9M | $135.6M | $53.7M | -$29.9M |
| Revenue * | $69.8M | $191.3M | $118.9M | $249.1M | $159.7M | $44.3M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.7M | -$8.2M | -$4.0M | -$9.7M | -$63.0K | $1.4M |
| Operating Income Loss | $24.8M | $142.2M | $77.8M | $202.2M | $121.5M | $14.2M |
| Operating Expenses | $45.0M | $49.1M | $41.1M | $46.9M | $38.2M | $30.1M |
| Nonoperating Income Expense | -$41.3M | -$32.5M | -$33.3M | -$32.9M | -$34.5M | -$33.1M |
| Net Income Loss Attributable To Noncontrolling Interest | -$1.1M | $16.9M | $6.0M | $22.2M | $21.5M | $12.4M |
| Income Tax Expense Benefit | $3.8M | $4.6M | $7.6M | $11.5M | $11.7M | -$1.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$16.5M | $109.7M | $44.5M | $169.3M | $87.0M | -$18.9M |
| General And Administrative Expense | $10.5M | $7.8M | $10.2M | $9.3M | $7.7M | $7.5M |
| Comprehensive Income Net Of Tax | -$16.5M | $80.1M | $26.9M | $126.0M | $53.7M | -$28.6M |
| Compensation Expense Excluding Cost Of Good And Service Sold | $5.1M | $5.1M | $4.2M | $4.8M | $4.9M | $4.8M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$17.6M | $96.9M | $32.9M | $148.2M | $75.2M | -$16.1M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$1.1M | $16.9M | $6.0M | $22.2M | $21.5M | $12.4M |
| Deferred Income Tax Expense Benefit | $6.3M | -$5.2M | ||||
| Income Taxes Paid | $427.0K | $384.0K | ||||
| Deferred Income Tax Liabilities Net | $51.8M | $46.2M | $42.2M | |||
| Deferred Income Tax Assets Net | $3.7M | $2.3M | $3.2M | |||
| Interest Expense Nonoperating | $41.5M | $34.0M | $33.9M | $34.4M | $34.5M | $32.6M |
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $2.3M | $1.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $2.45B | $2.42B | $2.29B | $1.74B | $1.70B | $1.76B | $1.87B | $1.50B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $566.4M | $469.9M | $220.5M | $107.7M | $180.3M | $322.1M | $273.4M | $395.5M |
| Goodwill | $134.0M | $133.9M | $134.0M | $133.9M | $134.0M | $134.0M | $134.0M | |
| Other Liabilities | $191.6M | $142.0M | $122.2M | $93.9M | $133.5M | $114.2M | $51.4M | |
| Other Assets | $73.7M | $61.0M | $63.5M | $51.9M | $48.2M | $49.6M | $13.3M | |
| Marketable Securities | $89.5M | $79.0M | $107.6M | $136.4M | $175.3M | $16.6M | $69.4M | |
| Liabilities | $3.51B | $2.92B | $2.63B | $1.90B | $1.63B | $1.24B | $1.12B | |
| Dividends Common Stock | $27.4M | $27.3M | $27.5M | $27.7M | $41.1M | $28.4M | ||
| Derivative Assets | $5.61B | $5.24B | $5.05B | $3.74B | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $94.6M | $249.9M | $111.6M | -$67.4M | -$140.8M | $48.2M | -$122.3M | |
| Assets | $6.64B | $6.18B | $5.84B | $4.29B | $3.74B | $3.27B | $2.65B | |
| Accrued Bonuses Current And Noncurrent | $228.4M | $217.6M | $183.1M | $71.4M | ||||
| Accounts Receivable Held At Fair Value | $164.8M | $183.9M | $265.5M | $116.6M | ||||
| Cash And Cash Equivalents At Carrying Value | $566.4M | $469.9M | $220.5M | $107.7M | $180.3M | $322.1M | $178.2M | |
| Treasury Stock Value Acquired Cost Method | $15.3M | $5.1M | $3.8M | $3.7M | ||||
| Retained Earnings Accumulated Deficit | $1.80B | $1.77B | $1.65B | $1.07B | $1.07B | $1.14B | ||
| Minority Interest | $679.7M | $837.4M | $916.9M | $644.5M | $412.1M | $260.4M | ||
| Liabilities And Stockholders Equity | $6.64B | $6.18B | $5.84B | $4.29B | $3.74B | $3.27B | ||
| Interest Payable Current And Noncurrent | $60.0M | $12.1M | $34.4M | $16.8M | $13.9M | $9.6M | ||
| Common Stock Value | $615.5M | $610.0M | $602.2M | $598.8M | $598.8M | $598.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$199.0K | $10.1M | $7.3M | $47.0M | $2.9M | $5.1M | ||
| Capital Provision Assets | $5.05B | $3.74B | $3.12B | $2.71B | $2.62B | $1.64B | ||
| Due From Settlement Of Capital Provision Assets | $265.5M | $116.6M | $86.3M | $30.7M | $48.1M | |||
| Adjustments To Additional Paid In Capital Retained Earnings Share Based Payment Arrangement | -$3.5M | -$4.3M | -$5.4M | $0.00 | ||||
| Treasury Stock Common Value | $24.9M | $9.6M | $4.5M | $3.7M | ||||
| Treasury Stock Common Shares | 1.8M | 669.9K | 350.9K | 468.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $2.50B | $2.50B | $2.43B | $3.30B | $3.23B | $3.13B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $677.7M | $372.2M | $486.6M | $574.0M | $390.7M | $482.7M |
| Goodwill | $134.0M | $134.0M | $134.0M | |||
| Other Liabilities | $193.7M | $192.5M | $192.7M | |||
| Other Assets | $78.9M | $70.8M | $65.8M | |||
| Marketable Securities | $79.1M | $84.3M | $83.5M | |||
| Liabilities | $3.50B | $3.10B | $3.02B | |||
| Dividends Common Stock | $0.00 | $13.7M | $0.00 | $13.7M | ||
| Derivative Assets | $5.62B | $5.54B | $5.31B | $5.36B | $5.24B | $5.10B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $16.0M | $262.3M | ||||
| Assets | $6.69B | $6.33B | $6.18B | |||
| Accrued Bonuses Current And Noncurrent | $214.9M | $211.2M | $197.3M | $209.5M | $193.0M | $180.1M |
| Accounts Receivable Held At Fair Value | $96.8M | $118.5M | $102.6M | $64.5M | $200.0M | $131.7M |
| Cash And Cash Equivalents At Carrying Value | $677.7M | $372.2M | $486.6M | |||
| Treasury Stock Value Acquired Cost Method | $15.3M | $0.00 | $712.0K | $4.4M | ||
| Retained Earnings Accumulated Deficit | $1.85B | $1.87B | $1.80B | |||
| Minority Interest | $691.2M | $725.4M | $726.2M | |||
| Liabilities And Stockholders Equity | $6.69B | $6.33B | $6.18B | |||
| Interest Payable Current And Noncurrent | $50.5M | $45.2M | $43.0M | |||
| Common Stock Value | $614.8M | $614.7M | $610.0M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $554.0K | -$2.1M | $6.1M | |||
| Capital Provision Assets | ||||||
| Due From Settlement Of Capital Provision Assets | ||||||
| Adjustments To Additional Paid In Capital Retained Earnings Share Based Payment Arrangement | -$846.0K | -$2.8M | -$93.0K | -$4.2M | ||
| Treasury Stock Common Value | $24.9M | $24.9M | $24.9M | |||
| Treasury Stock Common Shares | 1.8M | 1.8M | 1.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $13.8M | $8.7M | $8.7M | $7.8M | $8.8M | $5.3M | $4.5M | |
| Payments To Acquire Property Plant And Equipment | $284.0K | $661.0K | $3.2M | $407.0K | $285.0K | $360.0K | $3.4M | |
| Payments For Proceeds From Marketable Securities | $1.9M | -$32.6M | -$34.5M | -$27.9M | $160.4M | -$51.8M | -$3.3M | |
| Net Cash Provided By Used In Operating Activities | -$29.0M | $216.7M | -$274.7M | -$466.1M | -$585.4M | $53.8M | -$273.6M | |
| Net Cash Provided By Used In Investing Activities | -$8.8M | -$661.0K | -$3.2M | -$407.0K | -$285.0K | -$360.0K | -$3.4M | |
| Net Cash Provided By Used In Financing Activities | $132.4M | $33.8M | $389.5M | $399.1M | $444.8M | -$5.3M | $154.7M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.9M | -$515.0K | $1.3M | -$5.2M | -$1.0M | $472.0K | $199.0K | |
| Increase Decrease In Other Operating Liabilities | $108.5M | $35.0M | $156.3M | $19.1M | $25.1M | $20.4M | $37.8M | |
| Increase Decrease In Other Operating Assets | $6.4M | $1.5M | $3.6M | $5.5M | -$1.4M | $9.8M | -$3.8M | |
| Proceeds From Issuance Of Debt | $500.0M | $285.0M | $394.5M | $357.3M | $400.0M | |||
| Proceeds From Income Tax Refunds | $1.3M | $229.0K | $729.0K | $1.2M | ||||
| Payments For Repurchase Of Common Stock | $15.3M | $5.1M | $3.8M | $3.7M | ||||
| Payments For Proceeds From Financial Liabilities | $0.00 | $2.6M | $0.00 | -$3.3M | $96.3M | $42.2M | ||
| Proceeds From Asset Recovery Fee For Services | $734.0K | $2.4M | $1.6M | $1.1M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Share-Based Compensation * | $6.9M | $7.3M | $3.4M | $3.1M | $197.0K | $3.9M |
| Payments To Acquire Property Plant And Equipment | $24.0K | $43.0K | ||||
| Payments For Proceeds From Marketable Securities | $2.2M | -$5.7M | ||||
| Net Cash Provided By Used In Operating Activities | $155.2M | $53.0M | ||||
| Net Cash Provided By Used In Investing Activities | -$24.0K | -$43.0K | ||||
| Net Cash Provided By Used In Financing Activities | -$139.2M | $209.4M | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $733.0K | -$208.0K | ||||
| Increase Decrease In Other Operating Liabilities | $61.8M | -$21.2M | ||||
| Increase Decrease In Other Operating Assets | $6.1M | $200.0K | ||||
| Proceeds From Issuance Of Debt | $0.00 | $285.0M | ||||
| Proceeds From Income Tax Refunds | $0.00 | $98.0K | ||||
| Payments For Repurchase Of Common Stock | $15.3M | $4.4M | ||||
| Payments For Proceeds From Financial Liabilities | ||||||
| Proceeds From Asset Recovery Fee For Services |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 219.1M | 219.2M | 218.9M | 218.8M | 219.0M | 218.9M | 218.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 224.6M | 223.2M | 223.0M | 221.8M | 219.0M | 219.6M | 219.1M |
| Earnings Per Share Diluted | $0.28 | $0.66 | $2.74 | $0.14 | $-0.13 | $0.65 | $1.37 |
| Earnings Per Share Basic | $0.29 | $0.67 | $2.79 | $0.14 | $-0.13 | $0.65 | $1.37 |
| Common Stock Shares Outstanding | 218.9M | 219.4M | 219.0M | 218.6M | 219.0M | 219.0M | |
| Common Stock Shares Issued | 220.7M | 220.1M | 219.3M | 219.0M | 219.0M | 219.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 219.3M | 218.7M | 219.3M | 219.4M | 219.2M | 218.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 219.3M | 224.0M | 223.1M | 223.6M | 223.3M | 218.9M |
| Earnings Per Share Diluted | $-0.09 | $0.39 | $0.14 | $0.61 | $0.24 | $-0.14 |
| Earnings Per Share Basic | $-0.09 | $0.40 | $0.14 | $0.62 | $0.25 | $-0.14 |
| Common Stock Shares Outstanding | 218.8M | 218.8M | 218.3M | |||
| Common Stock Shares Issued | 220.6M | 220.6M | 220.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Salaries Wages And Officers Compensation | $48.4M | $42.4M | $39.8M | $34.2M | $34.3M | $31.5M | $25.2M |
| Foreign Currency Transaction Gain Loss Before Tax | $2.9M | -$1.4M | $21.8M | -$7.7M | -$5.5M | $10.7M | $2.0M |
| Expenditure Ineligible For Inclusion In Asset Cost | $14.6M | $801.0K | $16.5M | $8.2M | $5.3M | $4.8M | $11.2M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $21.9M | $13.0M | $14.1M | $10.3M | $9.3M | $5.3M | $4.5M |
| Interest Paid Net | $97.9M | $154.1M | $77.2M | $70.8M | $51.3M | $37.9M | $37.6M |
| Other Noncash Income Expense | -$4.9M | -$8.3M | $7.6M | -$18.0M | -$3.9M | $7.9M | $754.0K |
| Other Income | $617.0K | $3.1M | $4.4M | -$759.0K | $6.3M | ||
| Additional Paid In Capital | $56.8M | $42.4M | $36.5M | $26.3M | $26.4M | $22.5M | |
| Marketable Security Gain Loss And Interest Income | $28.8M | $25.0M | $12.2M | -$7.7M | |||
| Labor And Related Expense | $43.6M | $43.2M | $127.5M | $16.6M | |||
| Stock Issued During Period Value Restricted Stock Award Gross | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Salaries Wages And Officers Compensation | $11.2M | $11.7M | $12.4M | $10.2M | $10.9M | $11.7M |
| Foreign Currency Transaction Gain Loss Before Tax | $267.0K | $1.5M | $600.0K | $1.5M | -$67.0K | -$492.0K |
| Expenditure Ineligible For Inclusion In Asset Cost | $3.8M | $4.3M | $4.6M | $935.0K | $1.4M | $687.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.2M | $4.4M | $3.4M | $3.0M | $3.4M | $3.9M |
| Interest Paid Net | $1.9M | $24.5M | ||||
| Other Noncash Income Expense | -$1.2M | -$2.0M | ||||
| Other Income | $120.0K | $433.0K | -$186.0K | $2.0M | $250.0K | $284.0K |
| Additional Paid In Capital | $54.6M | $44.0M | $45.8M | |||
| Marketable Security Gain Loss And Interest Income | $6.8M | $8.6M | $6.8M | $8.2M | $6.3M | $6.6M |
| Labor And Related Expense | $7.5M | $12.9M | $6.9M | $18.6M | $13.0M | $1.6M |
| Stock Issued During Period Value Restricted Stock Award Gross | $0.00 | $0.00 | $0.00 | $0.00 |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.